Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T13:26:38.155Z.
Calculation as of: 2026-10-06T13:26:38.155Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ea8f5c362e28cab1379660d94c14b865908cd29a247cab29e6d5b71901c6c862
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-11-03.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$775.72M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$774.32M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$780.95M
EV/EBITDA Ratio
6.62x
TTM Avg
5.45x
3Y Avg
14.30x
5Y Avg
12.03x
Market Cap
$767.46M
EV/EBITDA Ratio
N/A
TTM Avg
867.40x
3Y Avg
862.35x
5Y Avg
862.35x
Market Cap
$786.48M
EV/EBITDA Ratio
N/A
TTM Avg
316.20x
3Y Avg
225.87x
5Y Avg
225.87x
Market Cap
$749.55M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$734.10M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Geron Corporation (GERN) | $776.24M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $780.95M | 6.62x | 5.45x | 14.30x | 12.03x |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | N/A | 867.40x | 862.35x | 862.35x |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | N/A | 316.20x | 225.87x | 225.87x |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $812.20M | 6.02x | 7.11x | 8.26x | 13.78x |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | N/A | 76.03x | 57.10x | 57.10x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2016-11-03 | 602.56x |
| 2016-11-02 | 616.27x |
| 2016-11-01 | 643.68x |
| 2016-10-31 | 616.27x |
| 2016-10-28 | 653.96x |
| 2016-10-27 | 671.10x |
| 2016-10-26 | 688.23x |
| 2016-10-25 | 691.66x |
| 2016-10-24 | 715.64x |
| 2016-10-21 | 708.79x |
| 2016-10-20 | 698.51x |
| 2016-10-19 | 695.08x |
| 2016-10-18 | 715.64x |
| 2016-10-17 | 695.08x |
| 2016-10-14 | 732.78x |
| 2016-10-13 | 739.63x |
| 2016-10-12 | 739.63x |
| 2016-10-11 | 791.03x |
| 2016-10-10 | 804.74x |
| 2016-10-07 | 767.04x |
| 2016-10-06 | 794.46x |
| 2016-10-05 | 767.04x |
| 2016-10-04 | 760.19x |
| 2016-10-03 | 767.04x |
| 2016-09-30 | 756.76x |
| 2016-09-29 | 736.20x |
| 2016-09-28 | 760.19x |
| 2016-09-27 | 756.76x |
| 2016-09-26 | 739.63x |
| 2016-09-23 | 736.20x |
| 2016-09-22 | 743.06x |
| 2016-09-21 | 753.34x |
| 2016-09-20 | 684.80x |
| 2016-09-19 | 667.67x |
| 2016-09-16 | 626.55x |
| 2016-09-15 | 657.39x |
| 2016-09-14 | 691.66x |
| 2016-09-13 | 725.92x |
| 2016-09-12 | 770.47x |
| 2016-09-09 | 962.37x |
| 2016-09-08 | 1027.47x |
| 2016-09-07 | 1027.47x |
| 2016-09-06 | 1017.19x |
| 2016-09-02 | 924.67x |
| 2016-09-01 | 917.82x |
| 2016-08-31 | 904.11x |
| 2016-08-30 | 904.11x |
| 2016-08-29 | 893.83x |
| 2016-08-26 | 907.54x |
| 2016-08-25 | 897.26x |
| 2016-08-24 | 890.41x |
| 2016-08-23 | 917.82x |
| 2016-08-22 | 921.25x |
| 2016-08-19 | 914.39x |
| 2016-08-18 | 917.82x |
| 2016-08-17 | 917.82x |
| 2016-08-16 | 921.25x |
| 2016-08-15 | 965.79x |
| 2016-08-12 | 921.25x |
| 2016-08-11 | 907.54x |
| 2016-08-10 | 890.41x |
| 2016-08-09 | 917.82x |
| 2016-08-08 | 914.39x |
| 2016-08-05 | 928.10x |
| 2016-08-04 | 910.97x |
